SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home » Executive Leadership » Abhijit Zutshi
Abhijit (Abhi) Zutshi brings 27 years of diverse commercial experience in the pharmaceutical industry, with deep expertise across B2B and B2C environments spanning both drug substances and drug products, as well as small and large molecules.
Abhi spent nearly 25 years at Biocon, where he built a distinguished career across sales, marketing, business development, asset acquisition, portfolio management, and market entry strategy. In 2006, he relocated to the United States to lead North American operations. Most recently, serving as Chief Commercial Officer for Biocon’s generics business, he oversaw both the drug substance and drug product divisions and spearheaded the creation of a global team dedicated to the generic formulations business.
Prior to Biocon, Abhi was a Product Specialist at Pfizer (formerly Wyeth Lederle), where he successfully launched the Zosyn brand in India.
A licensed pharmacist and MBA graduate, Abhi further sharpened his leadership acumen through the Leadership Development executive education program at Harvard Business School.
Outside of work, Abhi enjoys time with family and friends, motorsports, golf, cooking, and collecting vinyl records.